Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A native ternary complex trapped in crystal reveals the catalytic mechanism of a retaining glycosyltransferase

  • Albesa-Jové, David
  • Rodrigo-Unzueta, Ane
  • Gomollón-Bel, Fernando
  • Cifuente, Javier O.
  • Urresti, Saioa
  • Comino, Natalia
  • Sancho-Vaello, Enea
  • Merino, Pedro
  • Guerin, Marcelo E.
et al., Glycosyltransferases (GTs) comprise a prominent family of enzymes that play critical roles in a variety of cellular processes including cell signaling, cell development and host-pathogen interactions. Glycosyl transfer can proceed with either ‘inversion’ or ‘retention’ of the anomeric configuration with respect to the reaction substrates and products. The elucidation of the catalytic mechanism of retaining GTs remains a major challenge. We report the first native ternary complex of a GT, that of the retaining glucosyl-3-phosphoglycerate synthase GpgS from Mycobacterium tuberculosis, in the presence of the sugar donor UDP-Glc, the acceptor substrate phosphoglycerate and the divalent cation cofactor, in a productive mode for catalysis. In combination with structural, chemical, enzymatic, molecular dynamics and quantum-mechanics/molecular-mechanics (QM/MM) calculations, we unravel its catalytic mechanism, providing a strong experimental support for a front-side, substrate assisted SNi-type reaction., This work was supported by the EU Contract HEALTH-F3-2011-260872, MINECO Contract BIO2013-49022-C2-2-R, and the Basque Government (to M.E.G.); MINECO Contracts CTQ2011-24292 and CTQ2014-53144-P (to J.M.LL.) and “UAB - Banco Santander Program” (to L.M.); CTQ2013-44367-C2-1-P (to P.M.) and MINECO Contract BIO2013-49022-C2-1-R (to A.P). F.G.-B. and F.M. acknowledge support from the JAE Predoc Program (CSIC) and “Becas de Doctorado en el Extranjero - Becas Chile - CONICYT” Program, respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dissecting the structural and chemical determinants of the “open-to-closed” motion in the mannosyltransferase PimA from Mycobacteria

  • Rodrigo-Unzueta, Ane
  • Ghirardello, Mattia
  • Urresti, Saioa
  • Delso, J. Ignacio
  • Giganti, David
  • Anso, Itxaso
  • Trastoy, Beatriz
  • Comino, Natalia
  • Tersa, Montse
  • D’Angelo, Cecilia
  • Cifuente, Javier O.
  • Marina, Alberto
  • Liebau, Jobst
  • Mäler, Lena
  • Chenal, Alexandre
  • Albesa-Jové, David
  • Merino, Pedro
  • Guerin, Marcelo E.
The phosphatidyl-myo-inositol mannosyltransferase A (PimA) is an essential peripheral membrane glycosyltransferase that initiates the biosynthetic pathway of phosphatidyl-myo-inositol mannosides (PIMs), key structural elements and virulence factors of Mycobacterium tuberculosis. PimA undergoes functionally important conformational changes, including (i) α-helix-to-β-strand and β-strand-to-α-helix transitions and (ii) an “open-to-closed” motion between the two Rossmann-fold domains, a conformational change that is necessary to generate a catalytically competent active site. In previous work, we established that GDP-Man and GDP stabilize the enzyme and facilitate the switch to a more compact active state. To determine the structural contribution of the mannose ring in such an activation mechanism, we analyzed a series of chemical derivatives, including mannose phosphate (Man-P) and mannose pyrophosphate-ribose (Man-PP-RIB), and additional GDP derivatives, such as pyrophosphate ribose (PP-RIB) and GMP, by the combined use of X-ray crystallography, limited proteolysis, circular dichroism, isothermal titration calorimetry, and small angle X-ray scattering methods. Although the β-phosphate is present, we found that the mannose ring, covalently attached to neither phosphate (Man-P) nor PP-RIB (Man-PP-RIB), does promote the switch to the active compact form of the enzyme. Therefore, the nucleotide moiety of GDP-Man, and not the sugar ring, facilitates the “open-to-closed” motion, with the β-phosphate group providing the high-affinity binding to PimA. Altogether, the experimental data contribute to a better understanding of the structural determinants involved in the “open-to-closed” motion not only observed in PimA but also visualized and/or predicted in other glycosyltransfeases. In addition, the experimental data might prove to be useful for the discovery and/or development of PimA and/or glycosyltransferase inhibitors., This work was supported by grants from the European Commission, New Medicine for Tuberculosis, Contract LSHP-CT-2005-018923, and More Medicines for Tuberculosis, Contract HEALTH-F3-2011-260872 (M.E.G.); MARIE CURIE Reintegration Contract 844905 (B.T.); MINECO/FEDER EU Contracts SAF2010-19096, BIO2013-49022-C2-2-R, and BFU2016-77427-C2-2-R; Severo Ochoa Excellence Accreditation SEV-2016-0644 (M.E.G.); MINECO/FEDER EU Contract PID2019-104090RB-100 (P.M.); and “Juan de la Cierva Postdoctoral program” Contract IJCI-2014-19206 (B.T.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mycobacterial aminoglycoside acetyltransferases: A little of drug resistance, and a lot of other roles

  • Sanz-García, Fernando
  • Anoz-Carbonell, Ernesto
  • Pérez-Herrán, Esther
  • Martín, Carlos
  • Lucía, Ainhoa
  • Rodrigues, Liliana
  • Aínsa, José A.
© 2019 Sanz-García, Anoz-Carbonell, Pérez-Herrán, Martín, Lucía, Rodrigues and Aínsa., Aminoglycoside acetyltransferases are important determinants of resistance to aminoglycoside antibiotics in most bacterial genera. In mycobacteria, however, aminoglycoside acetyltransferases contribute only partially to aminoglycoside susceptibility since they are related with low level resistance to these antibiotics (while high level aminoglycoside resistance is due to mutations in the ribosome). Instead, aminoglycoside acetyltransferases contribute to other bacterial functions, and this can explain its widespread presence along species of genus Mycobacterium. This review is focused on two mycobacterial aminoglycoside acetyltransferase enzymes. First, the aminoglycoside 2′-N-acetyltransferase [AAC(2′)], which was identified as a determinant of weak aminoglycoside resistance in M. fortuitum, and later found to be widespread in most mycobacterial species; AAC(2′) enzymes have been associated with resistance to cell wall degradative enzymes, and bactericidal mode of action of aminoglycosides. Second, the Eis aminoglycoside acetyltransferase, which was identified originally as a virulence determinant in M. tuberculosis (enhanced intracellular survival); Eis protein in fact controls production of pro-inflammatory cytokines and other pathways. The relation of Eis with aminoglycoside susceptibility was found after the years, and reaches clinical significance only in M. tuberculosis isolates resistant to the second-line drug kanamycin. Given the role of AAC(2′) and Eis proteins in mycobacterial biology, inhibitory molecules have been identified, more abundantly in case of Eis. In conclusion, AAC(2′) and Eis have evolved from a marginal role as potential drug resistance mechanisms into a promising future as drug targets., FS-G and EA-C are recipients of FPU fellowships from the Spanish Ministry of Economy and Competitivity. JA acknowledges funding from the European Comission [More Medicines for Tuberculosis (MM4TB) grant 260872] and the Spanish Ministry of Economy and Competitivity (grants SAF-2013-48971-C2-2-R and SAF2017-84839-C2-1-R).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural basis for selective recognition of acyl chains by the membrane-associated acyltransferase PatA

  • Albesa-Jové, David
  • Svetlíková, Zuzana
  • Tersa, Montse
  • Sancho-Vaello, Enea
  • Carreras-González, Ana
  • Bonnet, Pascal
  • Arrasate, Pedro
  • Eguskiza, Ander
  • Angala, Shiva K
  • Cifuente, Javier O.
  • Korduláková, Jana
  • Jackson, Mary
  • Mikušová, Katarína
  • Guerin, Marcelo E.
The biosynthesis of phospholipids and glycolipids are critical pathways for virtually all cell membranes. PatA is an essential membrane associated acyltransferase involved in the biosynthesis of mycobacterial phosphatidyl-myo-inositol mannosides (PIMs). The enzyme transfers a palmitoyl moiety from palmitoyl-CoA to the 6-position of the mannose ring linked to 2-position of inositol in PIM1/PIM2. We report here the crystal structures of PatA from Mycobacterium smegmatis in the presence of its naturally occurring acyl donor palmitate and a nonhydrolyzable palmitoyl-CoA analog. The structures reveal an α/β architecture, with the acyl chain deeply buried into a hydrophobic pocket that runs perpendicular to a long groove where the active site is located. Enzyme catalysis is mediated by an unprecedented charge relay system, which markedly diverges from the canonical HX4D motif. Our studies establish the mechanistic basis of substrate/membrane recognition and catalysis for an important family of acyltransferases, providing exciting possibilities for inhibitor design., This work was supported by the European Commission Contract HEALTH-F3-2011-260872, the Spanish Ministry of Economy and Competitiveness Contract BIO2013-49022-C2-2-R, and the Basque Government (to M.E.G.); Slovak Research and Development Agency Contract No. DO7RP-0015-11 (to K.M.) and the NIH/NIAID grant AI064798 (to M.J.). D.A.-J. acknowledges the support from Fundación Biofisica Bizkaia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural basis of phosphatidyl-myo-inositol mannosides biosynthesis in mycobacteria

  • Sancho-Vaello, Enea
  • Albesa-Jové, David
  • Rodrigo-Unzueta, Ane
  • Guerin, Marcelo E.
Phosphatidyl-myo-inositol mannosides (PIMs) are glycolipids of unique chemical structure found in the inner and outer membranes of the cell envelope of all Mycobacterium species. The PIM family of glycolipids comprises phosphatidyl-myo-inositol mono-, di-, tri-, tetra-, penta-, and hexamannosides with different degrees of acylation. PIMs are considered not only essential structural components of the cell envelope but also the precursors of lipomannan and lipoarabinomannan, two major lipoglycans implicated in host-pathogen interactions. Since the description of the complete chemical structure of PIMs, major efforts have been committed to defining the molecular bases of its biosynthetic pathway. The structural characterization of the integral membrane phosphatidyl-myo-inositol phosphate synthase (PIPS), and that of three enzymes working at the protein-membrane interface, the phosphatidyl-myo-inositol mannosyltransferases A and B, and the acyltransferase PatA, established the basis of the early steps of the PIM pathway at the molecular level. This article is part of a Special Issue entitled: Bacterial Lipids edited by Russell E. Bishop., This work was supported by grants from the European Commission (contract HEALTH-F3-2011- 260872), MINECO (contract BIO2013-49022-C2-2-R), and the Basque Government (contact ETORTEK 2014) (to M.E.G.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis

  • Rosado, Leonardo Astolfi
  • Wahni, Khadija
  • Degiacomi, Giulia
  • Pedre, Brandán
  • Young, David
  • Rubia, Alfonso G. de la
  • Boldrin, Francesca
  • Martens, Edo
  • Marcos-Pascual, Laura
  • Sancho-Vaello, Enea
  • Albesa-Jové, David
  • Provvedi, Roberta
  • Martin, Charlotte
  • Makarov, Vadim
  • Versées, Wim
  • Verniest, Guido
  • Guerin, Marcelo E.
  • Mateos, Luis M
  • Manganelli, Riccardo
  • Messens, Joris
The Mycobacterium tuberculosis rv2466c gene encodes an oxidoreductase enzyme annotated as DsbA. It has a CPWC active-site motif embedded within its thioredoxin fold domain and mediates the activation of the prodrug TP053, a thienopyrimidine derivative that kills both replicating and nonreplicating bacilli. However, its mode of action and actual enzymatic function in M. tuberculosis have remained enigmatic. In this study, we report that Rv2466c is essential for bacterial survival under H2O2 stress. Further, we discovered that Rv2466c lacks oxidase activity; rather, it receives electrons through the mycothiol/mycothione reductase/NADPH pathway to activate TP053, preferentially via a dithiol–disulfide mechanism. We also found that Rv2466c uses a monothiol–disulfide exchange mechanism to reduce S-mycothiolated mixed disulfides and intramolecular disulfides. Genetic, phylogenetic, bioinformatics, structural, and biochemical analyses revealed that Rv2466c is a novel mycothiol-dependent reductase, which represents a mycoredoxin cluster of enzymes within the DsbA family different from the glutaredoxin cluster to which mycoredoxin-1 (Mrx1 or Rv3198A) belongs. To validate this DsbA–mycoredoxin cluster, we also characterized a homologous enzyme of Corynebacterium glutamicum (NCgl2339) and observed that it demycothiolates and reduces a mycothiol arsenate adduct with kinetic properties different from those of Mrx1. In conclusion, our work has uncovered a DsbA-like mycoredoxin that promotes mycobacterial resistance to oxidative stress and reacts with free mycothiol and mycothiolated targets. The characterization of the DsbA-like mycoredoxin cluster reported here now paves the way for correctly classifying similar enzymes from other organisms., This work was supported by grants from the European Commission (More Medicines for Tuberculosis, Contract HEALTH-F3–2011-260872) (to M. E. G. and R. M), the Spanish Ministry of Economy and Competitiveness (Contract BIO2013-49022-C2-2-R), the Basque Government (to M. E. G.), Agentschap voor Innovatie door Wetenschap en Technologie (IWT) (to B. P.), Vlaams Instituut voor Biotechnologie (VIB) (to J. M.), the SRP34 project of the Vrije Universiteit Brussel (VUB) (to J. M. and W. V.), Research Foundation Flanders (FWO) (to J. M.), Flanders Hercules Foundation (Grant HERC16) for the purification platform (to J. M.), and Junta Castilla y León Grants LE326U14 and ULE-UXXI-2016/00127 (to L. M. M.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural Basis of Glycogen Biosynthesis Regulation in Bacteria

  • Cifuente, Javier O.
  • Comino, Natalia
  • Madariaga-Marcos, Julene
  • López-Fernández, Sonia
  • García-Alija, Mikel
  • Agirre, Jon
  • Albesa-Jové, David
  • Guerin, Marcelo E.
ADP-glucose pyrophosphorylase (AGPase) catalyzes the rate-limiting step of bacterial glycogen and plant starch biosynthesis, the most common carbon storage polysaccharides in nature. A major challenge is to understand how AGPase activity is regulated by metabolites in the energetic flux within the cell. Here we report crystal structures of the homotetrameric AGPase from Escherichia coli in complex with its physiological positive and negative allosteric regulators, fructose-1,6-bisphosphate (FBP) and AMP, and sucrose in the active site. FBP and AMP bind to partially overlapping sites located in a deep cleft between glycosyltransferase A-like and left-handed β helix domains of neighboring protomers, accounting for the fact that sensitivity to inhibition by AMP is modulated by the concentration of the activator FBP. We propose a model in which the energy reporters regulate EcAGPase catalytic activity by intra-protomer interactions and inter-protomer crosstalk, with a sensory motif and two regulatory loops playing a prominent role., This work was supported by the European Commission contract HEALTH-F3-2011-260872, and the MINECO contract BIO2013-49022-C2-2-R (to M.E.G.). J.A. was supported by Biotechnology and Biological Sciences Research Council contract BB/K008153/1. We acknowledge DLS (beamline I04 and I04-1 under proposals 8302 and 10130) and SOLEIL. Access to structural biology facilities was supported in part by an EU FP7 infrastructure grant BIOSTRUCT-X (contract no. 283570)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The conformational plasticity of glycosyltransferases

  • Albesa-Jové, David
  • Guerin, Marcelo E.
Glycosyltransferases (GTs) catalyze the transfer of a sugar moiety from nucleotide-sugar or lipid-phospho-sugar donors to a broad range of acceptor substrates, generating a significant amount of structural diversity in biological systems. GTs are highly selective in nature, allowing the recognition of subtle structural differences in the sequences and stereochemistry of their sugar and acceptor substrates. To achieve the enzyme-transition state complex, a particular spatial arrangement of the active site is required, highlighting the importance of protein dynamics, conformational changes and plasticity of GTs during substrate recognition and catalysis. The elucidations of the molecular mechanisms by which these events govern the function and substrate specificity of GTs represent a major challenge., This work was supported by the European Commission Contract HEALTH-F3-2011-260872, the Spanish Ministry of Economy and Competitiveness Contract BIO2013-49022-C2-2-R and the Basque Government., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053

  • Albesa-Jové, David
  • Comino, Natalia
  • Tersa, Montse
  • Mohorko, Elisabeth
  • Urresti, Saioa
  • Dainese, Elisa
  • Chiarelli, Laurent R.
  • Pasca, Maria Rosalia
  • Manganelli, Riccardo
  • Makarov, Vadim
  • Riccardi, Giovanna
  • Svergun, Dmitri I.
  • Glockshuber, Rudi
  • Guerin, Marcelo E.
Rv2466c is a key oxidoreductase that mediates the reductive activation of TP053, a thienopyrimidine derivative that kills replicating and non-replicating Mycobacterium tuberculosis, but whose mode of action remains enigmatic. Rv2466c is a homodimer in which each subunit displays a modular architecture comprising a canonical thioredoxin-fold with a Cys19-Pro20-Trp21-Cys22 motif, and an insertion consisting of a four α-helical bundle and a short α-helical hairpin. Strong evidence is provided for dramatic conformational changes during the Rv2466c redox cycle, which are essential for TP053 activity. Strikingly, a new crystal structure of the reduced form of Rv2466c revealed the binding of a C-terminal extension in α-helical conformation to a pocket next to the active site cysteine pair at the interface between the thioredoxin domain and the helical insertion domain. The ab initio low-resolution envelopes obtained from small angle x-ray scattering showed that the fully reduced form of Rv2466c adopts a “closed” compact conformation in solution, similar to that observed in the crystal structure. In contrast, the oxidized form of Rv2466c displays an “open” conformation, where tertiary structural changes in the α-helical subdomain suffice to account for the observed conformational transitions. Altogether our structural, biochemical, and biophysical data strongly support a model in which the formation of the catalytic disulfide bond upon TP053 reduction triggers local structural changes that open the substrate binding site of Rv2466c allowing the release of the activated, reduced form of TP053. Our studies suggest that similar structural changes might have a functional role in other members of the thioredoxin-fold superfamily., This work was supported by European Commission Contract HEALTH-F3-2011-260872, the Spanish Ministry of Economy and Competitiveness Contract BIO2013-49022-C2-2-R, and the Basque Government (to M. E. G.), the European Commission FP7 Programme under BioStruct-X Grant 283570, Diamond Light Source Proposals mx8302/10130, and SOLEIL Proposal 20140843., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator

  • Gonzalo-Asensio, J.
  • Malaga, W.
  • Pawlik, A.
  • Astarie-Dequeker, C.
  • Passemar, C.
  • Moreau, F.
  • Laval, F.
  • Daffé, M.
  • Martin, C.
  • Brosch, R.
  • Guilhot, C.
Although the bovine tuberculosis (TB) agent, Mycobacterium bovis, may infect humans and cause disease, long-term epidemiological data indicate that humans represent a spill-over host in which infection with M. bovis is not self-maintaining. Indeed, human-to-human transmission of M. bovis strains and other members of the animal lineage of the tubercle bacilli is very rare. Here, we report on three mutations affecting the two-component virulence regulation system PhoP/PhoR (PhoPR) in M. bovis and in the closely linked Mycobacterium africanum lineage 6 (L6) that likely account for this discrepancy. Genetic transfer of these mutations into the human TB agent, Mycobacterium tuberculosis, resulted in down-regulation of the PhoP regulon, with loss of biologically active lipids, reduced secretion of the 6-kDa early antigenic target (ESAT-6), and lower virulence. Remarkably, the deleterious effects of the phoPR mutations were partly compensated by a deletion, specific to the animal-adapted and M. africanum L6 lineages, that restores ESAT-6 secretion by a PhoPR-independent mechanism. Similarly, we also observed that insertion of an IS6110 element upstream of the phoPR locus may completely revert the phoPR-bovis–associated fitness loss, which is the case for an exceptional M. bovis human outbreak strain from Spain. Our findings ultimately explain the long-term epidemiological data, suggesting that M. bovis and related phoPR-mutated strains pose a lower risk for progression to overt human TB, with major impact on the evolutionary history of TB.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Boldine-derived Alkaloids inhibit the activity of DNA topoisomerase I and growth of Mycobacterium tuberculosis

  • García, M.T.
  • Carreño, D.
  • Tirado-Vélez, J.M.
  • Ferrándiz, M.J.
  • Rodrigues, L.
  • Gracia, B.
  • Amblar, M.
  • Ainsa, J.A.
  • de la Campa, A.G.
The spread of multidrug-resistant isolates of Mycobacterium tuberculosis requires the discovery of new drugs directed to new targets. In this study, we investigated the activity of two boldine-derived alkaloids, seconeolitsine (SCN) and N-methyl-seconeolitsine (N-SCN), against M. tuberculosis. These compounds have been shown to target DNA topoisomerase I enzyme and inhibit growth of Streptococcus pneumoniae. Both SCN and N-SCN inhibited M. tuberculosis growth at 1.95-15.6 µM, depending on the strain. In M. smegmatis this inhibitory effect correlated with the amount of topoisomerase I in the cell, hence demonstrating that this enzyme is the target for these alkaloids in mycobacteria. The gene coding for topoisomerase I of strain H37Rv (MtbTopoI) was cloned into pQE1 plasmid of Escherichia coli. MtbTopoI was overexpressed with an N-terminal 6-His-tag and purified by affinity chromatography. In vitro inhibition of MtbTopoI activity by SCN and N-SCN was tested using a plasmid relaxation assay. Both SCN and N-SCN inhibited 50% of the enzymatic activity at 5.6 and 8.4 µM, respectively. Cleavage of single-stranded DNA was also inhibited with SCN. The effects on DNA supercoiling were also evaluated in vivo in plasmid-containing cultures of M. tuberculosis. Plasmid supercoiling densities were -0.060 in cells untreated or treated with boldine, and -0.072 in 1 × MIC N-SCN treated cells, respectively, indicating that the plasmid became hypernegatively supercoiled in the presence of N-SCN. Altogether, these results demonstrate that the M. tuberculosis topoisomerase I enzyme is an attractive drug target, and that SCN and N-SCN are promising lead compounds for drug development.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Mycobacterial aminoglycoside acetyltransferases: a little of drug resistance, and a lot of other roles

  • Sanz-García, F.
  • Anoz-Carbonell, E.
  • Pérez-Herrán, E.
  • Martín, C.
  • Lucía, A.
  • Rodrigues, L.
  • Aínsa, J.A.
Aminoglycoside acetyltransferases are important determinants of resistance to aminoglycoside antibiotics in most bacterial genera. In mycobacteria, however, aminoglycoside acetyltransferases contribute only partially to aminoglycoside susceptibility since they are related with low level resistance to these antibiotics (while high level aminoglycoside resistance is due to mutations in the ribosome). Instead, aminoglycoside acetyltransferases contribute to other bacterial functions, and this can explain its widespread presence along species of genus Mycobacterium. This review is focused on two mycobacterial aminoglycoside acetyltransferase enzymes. First, the aminoglycoside 2'-N-acetyltransferase [AAC(2')], which was identified as a determinant of weak aminoglycoside resistance in M. fortuitum, and later found to be widespread in most mycobacterial species; AAC(2') enzymes have been associated with resistance to cell wall degradative enzymes, and bactericidal mode of action of aminoglycosides. Second, the Eis aminoglycoside acetyltransferase, which was identified originally as a virulence determinant in M. tuberculosis (enhanced intracellular survival); Eis protein in fact controls production of pro-inflammatory cytokines and other pathways. The relation of Eis with aminoglycoside susceptibility was found after the years, and reaches clinical significance only in M. tuberculosis isolates resistant to the second-line drug kanamycin. Given the role of AAC(2') and Eis proteins in mycobacterial biology, inhibitory molecules have been identified, more abundantly in case of Eis. In conclusion, AAC(2') and Eis have evolved from a marginal role as potential drug resistance mechanisms into a promising future as drug targets.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria

  • Singh, Vinayak
  • Dhar, Neeraj
  • Pató, János
  • Kolly, Gaëlle S.
  • Korduláková, Jana
  • Forbak, Martin
  • Evans, Joanna C.
  • Székely, Rita
  • Rybniker, Jan
  • Palceková, Zuzana
  • Zemanová, Júlia
  • Santi, Isabella
  • Signorino-Gelo, François
  • Rodrigues, Liliana
  • Vocat, Anthony
  • Covarrubias, Adrian S.
  • Rengifo, Monica G.
  • Johnsson, Kai
  • Mowbray, Sherry
  • Buechler, Joseph
  • Delorme, Vincent
  • Brodin, Priscille
  • Knott, Graham W.
  • Aínsa, José A.
  • Warner, Digby F.
  • Kéri, G.
  • Mikušová, Katarina
  • McKinney, John D.
  • Cole, Stewark T.
  • Mizrahi, Valerie
  • Hartkoorn, Ruben C.
There is an urgent need to discover new anti-tubercular agents with novel mechanisms of action in order to tackle the scourge of drug-resistant tuberculosis. Here, we report the identification of such a molecule – an AminoPYrimidine-Sulfonamide (APYS1) that has potent, bactericidal activity against M. tuberculosis. Mutations in APYS1-resistant M. tuberculosis mapped exclusively to wag31, a gene that encodes a scaffolding protein thought to orchestrate cell elongation. Recombineering confirmed that a Gln201Arg mutation in Wag31 was sufficient to cause resistance to APYS1, however, neither overexpression nor conditional depletion of wag31 impacted M. tuberculosis susceptibility to this compound. In contrast, expression of the wildtype allele of wag31 in APYS1-resistant M. tuberculosis was dominant and restored susceptibility to APYS1 to wildtype levels. Time-lapse imaging and scanning electron microscopy revealed that APYS1 caused gross malformation of the old pole of M. tuberculosis, with eventual lysis. These effects resembled the morphological changes observed following transcriptional silencing of wag31 in M. tuberculosis. These data show that Wag31 is likely not the direct target of APYS1, but the striking phenotypic similarity between APYS1 exposure and genetic depletion of Wag31 in M. tuberculosis suggests that APYS1 might indirectly affect Wag31 through an as yet unknown mechanism.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis

  • García Esteban, María Teresa
  • Carreño, David
  • Tirado Vélez, José Manuel
  • Ferrándiz, María José
  • Rodrigues, Liliana
  • Gracia, Begoña
  • Amblar, Mónica
  • Ainsa, José A.
  • Gonzalez de la Campa, Adela
The spread of multidrug-resistant isolates of Mycobacterium tuberculosis requires the discovery of new drugs directed to new targets. In this study, we investigated the activity of two boldine-derived alkaloids, seconeolitsine (SCN) and N-methyl-seconeolitsine (N-SCN), against M. tuberculosis. These compounds have been shown to target DNA topoisomerase I enzyme and inhibit growth of Streptococcus pneumoniae. Both SCN and N-SCN inhibited M. tuberculosis growth at 1.95–15.6 μM, depending on the strain. In M. smegmatis this inhibitory effect correlated with the amount of topoisomerase I in the cell, hence demonstrating that this enzyme is the target for these alkaloids in mycobacteria. The gene coding for topoisomerase I of strain H37Rv (MtbTopoI) was cloned into pQE1 plasmid of Escherichia coli. MtbTopoI was overexpressed with an N-terminal 6-His-tag and purified by affinity chromatography. In vitro inhibition of MtbTopoI activity by SCN and N-SCN was tested using a plasmid relaxation assay. Both SCN and N-SCN inhibited 50% of the enzymatic activity at 5.6 and 8.4 μM, respectively. Cleavage of single-stranded DNA was also inhibited with SCN. The effects on DNA supercoiling were also evaluated in vivo in plasmid-containing cultures of M. tuberculosis. Plasmid supercoiling densities were −0.060 in cells untreated or treated with boldine, and −0.072 in 1 × MIC N-SCN treated cells, respectively, indicating that the plasmid became hypernegatively supercoiled in the presence of N-SCN. Altogether, these results demonstrate that the M. tuberculosis topoisomerase I enzyme is an attractive drug target, and that SCN and N-SCN are promising lead compounds for drug development.